Design Therapeutics
Stock Forecast, Prediction & Price Target
Design Therapeutics Financial Estimates
Design Therapeutics Revenue Estimates
Design Therapeutics EBITDA Estimates
Design Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $48.52M Low: $48.52M High: $48.52M avg. 0% | Avg: $117.33M Low: $117.33M High: $117.33M avg. 141.78% | Avg: $204.77M Low: $204.77M High: $204.77M avg. 74.52% | Avg: $10M Low: $10M High: $10M avg. -95.11% |
Net Income
% change YoY
| $-35.53M N/A | $-58.61M -64.96% | $-66.86M -14.06% | Avg: $-77.08M Low: $-81.73M High: $-62.69M avg. -15.28% | Avg: $-97.09M Low: $-73.89M High: $-73.89M avg. -25.96% | Avg: $-61.01M Low: $-61.01M High: $-61.01M avg. 37.15% | Avg: $-79.49M Low: $-79.49M High: $-79.49M avg. -30.27% |
EBITDA
% change YoY
| $-35.70M N/A | $-67.59M -89.32% | $-66.32M 1.87% | Avg: $9.70M Low: $9.70M High: $9.70M avg. 114.63% | Avg: $23.46M Low: $23.46M High: $23.46M avg. 141.78% | Avg: $40.95M Low: $40.95M High: $40.95M avg. 74.52% | Avg: $1.99M Low: $1.99M High: $1.99M avg. -95.11% |
EPS
% change YoY
| -$0.77 N/A | -$1.05 -36.36% | -$1.19 -13.33% | Avg: -$1.29 Low: -$1.46 High: -$1.12 avg. -8.40% | Avg: -$1.32 Low: -$1.32 High: -$1.32 avg. -2.32% | Avg: -$1.09 Low: -$1.09 High: -$1.09 avg. 17.42% | Avg: -$1.42 Low: -$1.42 High: -$1.42 avg. -30.27% |
Operating Expenses
% change YoY
| $35.83M N/A | $67.59M 88.64% | $78.19M 15.67% | Avg: $119.88B Low: $119.88B High: $119.88B avg. 153220.97% | Avg: $289.84B Low: $289.84B High: $289.84B avg. 141.78% | Avg: $505.87B Low: $505.87B High: $505.87B avg. 74.52% | Avg: $24.70B Low: $24.70B High: $24.70B avg. -95.11% |
FAQ
What is Design Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -8.59% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -81.73M, average is -77.08M and high is -62.69M.
What is Design Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 30.29% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $48.52M, average is $48.52M and high is $48.52M.
What is Design Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -5.89% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$1.46, average is -$1.29 and high is $-1.12.
What is the best performing analyst?
In the last twelve months analysts have been covering Design Therapeutics stock. The most successful analyst is Yasmeen Rahimi.